Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $18,850 | 4 | 92.7% |
| Travel and Lodging | $770.98 | 2 | 3.8% |
| Food and Beverage | $707.76 | 12 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $13,438 | 16 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $6,825 | 1 | $0 (2017) |
| CARDIVA MEDICAL, INC. | $66.06 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $66.06 | 1 | CARDIVA MEDICAL, INC. ($66.06) |
| 2020 | $7,465 | 3 | GlaxoSmithKline, LLC. ($7,465) |
| 2019 | $5,973 | 13 | GlaxoSmithKline, LLC. ($5,973) |
| 2017 | $6,825 | 1 | Merck Sharp & Dohme Corporation ($6,825) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/01/2023 | CARDIVA MEDICAL, INC. | — | Food and Beverage | In-kind items and services | $66.06 | General |
| 09/10/2020 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,625.00 | General |
| 04/18/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Consulting Fee | Cash or cash equivalent | $5,200.00 | General |
| Category: RESPIRATORY | ||||||
| 04/18/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Travel and Lodging | Cash or cash equivalent | $639.73 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $58.44 | General |
| 12/06/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $49.75 | General |
| 12/06/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $26.39 | General |
| 12/06/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $16.20 | General |
| 12/05/2019 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $131.25 | General |
| 12/05/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $84.17 | General |
| 10/09/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Consulting Fee | Cash or cash equivalent | $5,200.00 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $87.51 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $83.15 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $52.78 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $31.36 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 06/23/2017 | Merck Sharp & Dohme Corporation | DULERA (Drug) | Consulting Fee | Cash or cash equivalent | $6,825.00 | General |
| Category: RESPIRATORY | ||||||
About Dr. Lewis Smith, MD
Dr. Lewis Smith, MD is a Pulmonary Disease healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225124753.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lewis Smith, MD has received a total of $20,329 in payments from pharmaceutical and medical device companies, with $66.06 received in 2023. These payments were reported across 18 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($18,850).
Practice Information
- Specialty Pulmonary Disease
- Location Chicago, IL
- Active Since 10/04/2006
- Last Updated 07/09/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1225124753
Products in Payments
- TRELEGY ELLIPTA (Drug) $11,446
- DULERA (Drug) $6,825
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Chicago
Douglas Hogarth
Pulmonary Disease — Payments: $3.0M
Septimiu Murgu
Pulmonary Disease — Payments: $1.0M
Steven White
Pulmonary Disease — Payments: $685,389
Ayodeji Adegunsoye
Pulmonary Disease — Payments: $504,729
Brian Garibaldi, M.d, M.D
Pulmonary Disease — Payments: $355,981
Dr. Ravi Kalhan, M.d, M.D
Pulmonary Disease — Payments: $327,619